ZY

Zhizhong Yao

Partner at Sofinnova Partners

Greater Paris Metropolitan Region

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner - Sofinnova Acceleration Strategy BiovelocITA

    2023

  • Principal - Sofinnova Capital Strategy

    2015 - 2024

    Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, with offices in London and Milan.

2021 - 2024

  • Board Observer

    2021 - 2024

2019 - 2024

  • Kauffman Fellow, class 24

    2019 - 2024

    Kauffman Fellows is the leadership organization in innovation and capital formation, with graduates leading venture capital, government, corporate, university, and startup innovation efforts globally.

  • Board Observer

    2019 - 2024

    Mnemo Tx is a "next generation"CAR-T company focused on the treatment of solid tumors.

  • Board Observer

    2019 - 2024

    Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform.

2018 - 2020

  • Board Observer

    2018 - 2020

    NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation.

  • Human Frontier Science Program (Cross-disciplinary Fellows)

    2013 - 2015